Sequentify
PrivateLast Round
Grant
Jan 11, 2024
Total Funding Raised
$7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sequentify is a biotechnology company that provides library-preparation solutions and AI software for next-generation sequencing to enable faster and more cost-effective genomic testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sequentify Comparables
Compare Sequentify with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micronbrane Medical | 79% | |
| SeqWell | 79% | |
| Quantabio | 76% |
Sequentify Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 11, 2024 | ||||
| Seed | May 10, 2022 |
Sequentify Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 226% MoM, reaching 2K.
- Jul 31, 2025
Appointed Dr. Ravi Majeti, an expert in hematologic malignancies.
Sequentify Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access